Sangamo Therapeutics (SGMO) Q2 2025 Earnings

May 12Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.18
-0.11
-0.03
0.04

Details

Expected EPS
-0.117286
Actual EPS
-0.14
Surprise EPS
-0.02
Surprise Percent
-19.37%

Description

⁨Sangamo Therapeutics⁩ (⁦SGMO⁩) has reported earnings of ⁦-0.14⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts